학술논문
P094 A Phase II study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of BI 1291583 in patients with cystic fibrosis bronchiectasis (the Clairafly™ study)
Document Type
Abstract
Author
Source
In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S92-S92
Subject
Language
ISSN
1569-1993